Neurocritical Care

, Volume 16, Issue 1, pp 184–193

Gastrointestinal Prophylaxis in Neurocritical Care

  • Clemens M. Schirmer
  • Joshua Kornbluth
  • Carl B. Heilman
  • Anish Bhardwaj
Review Article

Abstract

The aim of this study is to review and summarize the relevant literature regarding pharmacologic and non-pharmacologic methods of prophylaxis against gastrointestinal (GI) stress ulceration, and upper gastrointestinal bleeding in critically ill patients. Stress ulcers are a known complication of a variety of critical illnesses. The literature regarding epidemiology and management of stress ulcers and complications thereof, is vast and mostly encompasses patients in medical and surgical intensive care units. This article aims to extrapolate meaningful data for use with a population of critically ill neurologic and neurosurgical patients in the neurological intensive care unit setting. Studies were identified from the cochrane central register of controlled trials and NLM PUBMED for english articles dealing with an adult population. We also scanned bibliographies of relevant studies. The results show that H2A, sucralfate, and PPI all reduce the incidence of UGIB in neurocritically ill patients, but H2A blockers may cause encephalopathy and interact with anticonvulsant drugs, and have been associated with higher rates of nosocomial pneumonias, but causation remains unproven and controversial. For these reasons, we advocate against routine use of H2A for GI prophylaxis in neurocritical patients. There is a paucity of high-level evidence studies that apply to the neurocritical care population. From this study, it is concluded that stress ulcer prophylaxis among critically ill neurologic and neurosurgical patients is important in preventing ulcer-related GI hemorrhage that contributes to both morbidity and mortality. Further, prospective trials are needed to elucidate which methods of prophylaxis are most appropriate and efficacious for specific illnesses in this population.

Keywords

Gastrointestinal Neurocritical Ulcer Prophylaxis GI bleed 

References

  1. 1.
    Chan KH, Mann KS, Lai EC, Ngan J, Tuen H, Yue CP. Factors influencing the development of gastrointestinal complications after neurosurgery: results of multivariate analysis. Neurosurgery. 1989;25(3):378–82.PubMedCrossRefGoogle Scholar
  2. 2.
    Leramo OB, Tator CH, Hudson AR. Massive gastroduodenal hemorrhage and perforation in acute spinal cord injury. Surg Neurol. 1982;17(3):186–90.PubMedCrossRefGoogle Scholar
  3. 3.
    Misra UK, Kalita J, Pandey S, Mandal SK. Predictors of gastrointestinal bleeding in acute intracerebral haemorrhage. J Neurol Sci. 2003;208(1–2):25–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Misra UK, Kalita J, Pandey S, Mandal SK, Srivastava M. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci. 2005;239(1):5–10.PubMedCrossRefGoogle Scholar
  5. 5.
    O’Donnell MJ, Kapral MK, Fang J, Saposnik G, Eikelboom JW, Oczkowski W, Silva J, Gould L, D’Uva C, Silver FL. Gastrointestinal bleeding after acute ischemic stroke. Neurology. 2008;71(9):650–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Schaller BJ, Graf R, Jacobs AH. Pathophysiological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol. 2006;101(7):1655–65.PubMedCrossRefGoogle Scholar
  7. 7.
    Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian critical care trials group. Crit Care Med. 1999;27(12):2812–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Yang YX, Lewis JD. Prevention and treatment of stress ulcers in critically ill patients. Semin Gastrointest Dis. 2003;14(1):11–9.PubMedGoogle Scholar
  9. 9.
    Cushing H. Peptic ulcer and the interbrain. Surg Obst. 1932;55:1–34.Google Scholar
  10. 10.
    Rokitansky C. Handbuch der pathologischen Anatomie, vol 3. Braunmueller und Seidel: Wien;1842 p. 197.Google Scholar
  11. 11.
    Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002;30(6 Suppl):S351–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Idjadi F, Robbins R, Stahl WM, Essiet G. Prospective study of gastric secretion in stressed patients with intracranial injury. J Trauma. 1971;11(8):681–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care. 2009;15(2):139–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64(10):935–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Kamada T, Fusamoto H, Kawano S, Noguchi M, Hiramatsu K. Gastrointestinal bleeding following head injury: a clinical study of 433 cases. J Trauma. 1977;17(1):44–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119(4):1222–41.PubMedCrossRefGoogle Scholar
  17. 17.
    Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996;275(4):308–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, Kirby A, Tryba M. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368–75.PubMedCrossRefGoogle Scholar
  19. 19.
    Sesler JM. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN Adv Crit Care. 2007;18(2):119–26. quiz 127-8.PubMedCrossRefGoogle Scholar
  20. 20.
    Karch SB. Upper gastrointestinal bleeding as a complication of intracranial disease. J Neurosurg. 1972;37(1):27–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Chan KH, Mann KS. Failure of cimetidine prophylaxis in neurosurgery. Aust N Z J Surg. 1989;59(2):133–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Chan KH, Lai EC, Tuen H, Ngan JH, Mok F, Fan YW, Fung CF, Yu WC. Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients. J Neurosurg. 1995;82(3):413–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Gordon MJ, Skillman JJ, Zervas NT, Silen W. Divergent nature of gastric mucosal permeability and gastric acid secretion in sick patients with general surgical and neurosurgical disease. Ann Surg. 1973;178(3):285–94.PubMedCrossRefGoogle Scholar
  24. 24.
    Reusser P, Gyr K, Scheidegger D, Buchmann B, Buser M, Zimmerli W. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. Crit Care Med. 1990;18(3):270–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Bowen JC, Fleming WH, Thompson JC. Increased gastrin release following penetrating central nervous system injury. Surgery. 1974;75(5):720–4.PubMedGoogle Scholar
  26. 26.
    Gudeman SK, Wheeler CB, Miller JD, Halloran LG, Becker DP. Gastric secretory and mucosal injury response to severe head trauma. Neurosurgery. 1983;12(2):175–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Halloran LG, Zfass AM, Gayle WE, Wheeler CB, Miller JD. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. Am J Surg. 1980;139(1):44–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Hatton J, Lu WY, Rhoney DH, Tibbs PA, Dempsey RJ, Young B. A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit. Surg Neurol. 1996;46(5):493–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Burgess P, Larson GM, Davidson P, Brown J, Metz CA. Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury. Dig Dis Sci. 1995;40(3):645–50.PubMedCrossRefGoogle Scholar
  30. 30.
    Metz CA, Livingston DH, Smith JS, Larson GM, Wilson TH. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. The ranitidine head injury study group. Crit Care Med. 1993;21(12):1844–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Norton L, Greer J, Eiseman B. Gastric secretory response to head injury. Arch Surg. 1970;101(2):200–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Watts CC, Clark K. Gastric acidity in the comatose patient. J Neurosurg. 1969;30(2):107–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Brown TH, Davidson PF, Larson GM. Acute gastritis occurring within 24 hours of severe head injury. Gastrointest Endosc. 1989;35(1):37–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Li ZM, Wang LX, Jiang LC, Zhu JX, Geng FY, Qiang F. Relationship between plasma cortisol levels and stress ulcer following acute and severe head injury. Med Princ Pract. 2010;19(1):17–21.PubMedCrossRefGoogle Scholar
  35. 35.
    Epstein N, Hood DC, Ransohoff J. Gastrointestinal bleeding in patients with spinal cord trauma. Effects of steroids, cimetidine, and mini-dose heparin. J Neurosurg. 1981;54(1):16–20.PubMedCrossRefGoogle Scholar
  36. 36.
    Gore RM, Mintzer RA, Calenoff L. Gastrointestinal complications of spinal cord injury. Spine (Phila Pa 1976). 1981;6(6):538–44.CrossRefGoogle Scholar
  37. 37.
    Kiwerski J. Bleeding from the alimentary canal during the management of spinal cord injury patients. Paraplegia. 1986;24(2):92–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Kuric J, Lucas CE, Ledgerwood AM, Kiraly A, Salciccioli GG, Sugawa C. Nutritional support: a prophylaxis against stress bleeding after spinal cord injury. Paraplegia. 1989;27(2):140–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Walters K, Silver JR. Gastrointestinal bleeding in patients with acute spinal injuries. Int Rehabil Med. 1986;8(1):44–7.PubMedGoogle Scholar
  40. 40.
    El Masri WE, Cochrane P, Silver JR. Gastrointestinal bleeding in patients with acute spinal injuries. Injury. 1982;14(2):162–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Albert TJ, Levine MJ, Balderston RA, Cotler JM. Gastrointestinal complications in spinal cord injury. Spine (Phila Pa 1976). 1991;16(10 Suppl):S522–5.CrossRefGoogle Scholar
  42. 42.
    Soderstrom CA, Ducker TB. Increased susceptibility of patients with cervical cord lesions to peptic gastrointestinal complications. J Trauma. 1985;25(11):1030–8.PubMedGoogle Scholar
  43. 43.
    Filaretova L, Morozova O, Bagaeva T, Podvigina T. From gastroprotective to proulcerogenic action of glucocorticoids on the gastric mucosa. J Physiol Pharmacol. 2009;60(Suppl 7):79–86.PubMedGoogle Scholar
  44. 44.
    Westwell S. Implementing a ventilator care bundle in an adult intensive care unit. Nurs Crit Care. 2008;13(4):203–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Davenport RJ, Dennis MS, Warlow CP. Gastrointestinal hemorrhage after acute stroke. Stroke. 1996;27(3):421–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Wijdicks EF, Fulgham JR, Batts KP. Gastrointestinal bleeding in stroke. Stroke. 1994;25(11):2146–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Hamidon BB, Raymond AA. The risk factors of gastrointestinal bleeding in acute ischaemic stroke. Med J Malaysia. 2006;61(3):288–91.PubMedGoogle Scholar
  48. 48.
    Tsuchiya J, Ito Y, Hino T, Ohashi H, Kunieda T, Sakata K. Stress ulcer accompanying subarachnoid hemorrhage—a new rat model. Jpn J Surg. 1983;13(4):373–80.PubMedCrossRefGoogle Scholar
  49. 49.
    Sakata K, Nonomura O, Ito Y, Tsuchiya J, Ohashi H. Neurogenic stress gastric ulceration—an experimental study in rats. No Shinkei Geka. 1987;15(10):1057–63.PubMedGoogle Scholar
  50. 50.
    Iberti TJ. Hemodynamic effects of H2-receptor antagonists. DICP. 1990;24(11 Supp):S35–7.PubMedGoogle Scholar
  51. 51.
    Ostro MJ. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists. Am J Med. 1987;83(6A):15–22.PubMedCrossRefGoogle Scholar
  52. 52.
    Yue CP, Mann KS, Chan KH. Severe thrombocytopenia due to combined cimetidine and phenytoin therapy. Neurosurgery. 1987;20(6):963–5.PubMedCrossRefGoogle Scholar
  53. 53.
    Messori A, Trippoli S, Vaiani M, Gorini M, Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2000;321(7269):1103–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Kimelblatt BJ, Cerra FB, Calleri G, Berg MJ, McMillen MA, Schentag JJ. Dose and serum concentration relationships in cimetidine-associated mental confusion. Gastroenterology. 1980;78(4):791–5.PubMedGoogle Scholar
  55. 55.
    Lacroix J, Infante-Rivard C, Jenicek M, Gauthier M. Prophylaxis of upper gastrointestinal bleeding in intensive care units: a meta-analysis. Crit Care Med. 1989;17(9):862–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med. 1991;19(7):942–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Martin LF, Booth FV, Karlstadt RG, Silverstein JH, Jacobs DM, Hampsey J, Bowman SC, D’Ambrosio CA, Rockhold FW. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med. 1993;21(1):19–30.PubMedCrossRefGoogle Scholar
  58. 58.
    Glavin GB. Role of the central nervous system in stress ulcers. Compr Ther. 1991;17(4):3–5.PubMedGoogle Scholar
  59. 59.
    Lu WY, Rhoney DH, Boling WB, Johnson JD, Smith TC. A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery. 1997;41(2):416–25. discussion 425-6.PubMedCrossRefGoogle Scholar
  60. 60.
    Yang YX, Metz DC. Safety of proton pump inhibitor exposure. Gastroenterology. 2010;139(4):1115–27.PubMedCrossRefGoogle Scholar
  61. 61.
    Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (omeprazole clopidogrel aspirin) study. J Am Coll Cardiol. 2008;51(3):256–60.PubMedCrossRefGoogle Scholar
  62. 62.
    Siriswangvat S, Sansanayudh N, Nathisuwan S, Panomvana D. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel. Circ J. 2010;74(10):2187–92.PubMedCrossRefGoogle Scholar
  63. 63.
    Lin PC, Chang CH, Hsu PI, Tseng PL, Huang YB. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med. 2010;38(4):1197–205.PubMedCrossRefGoogle Scholar
  64. 64.
    Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess. 2007;11(51):1–164, iii–iv.Google Scholar
  65. 65.
    Morrissey JF, Barreras RF. Drug therapy. Antacid therapy. N Engl J Med. 1974;290(10):550–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian critical care trials group. N Engl J Med. 1994;330(6):377–81.PubMedCrossRefGoogle Scholar
  67. 67.
    Slomiany BL, Piotrowski J, Okazaki K, Grzelinska E, Slomiany A. Nature of the enhancement of the protective qualities of gastric mucus by sucralfate. Digestion. 1989;44(4):222–31.PubMedCrossRefGoogle Scholar
  68. 68.
    Tryba M. Stress bleeding prophylaxis with sucralfate. Pathophysiologic basis and clinical use. Scand J Gastroenterol Suppl. 1990;173:22–33.PubMedCrossRefGoogle Scholar
  69. 69.
    Chen BW, Hiu WM, Lam SK, Cho CH, Ng MM, Luk CT. Effect of sucralfate on gastric mucosal blood flow in rats. Gut. 1989;30(11):1544–51.PubMedCrossRefGoogle Scholar
  70. 70.
    McCarthy DM. Sucralfate. N Engl J Med. 1991;325(14):1017–25.PubMedCrossRefGoogle Scholar
  71. 71.
    Eddleston JM, Vohra A, Scott P, Tooth JA, Pearson RC, McCloy RF, Morton AK, Doran BH. A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate-or ranitidine-treated intensive care unit patients. Crit Care Med. 1991;19(12):1491–6.PubMedCrossRefGoogle Scholar
  72. 72.
    Tryba M. Prophylaxis of stress ulcer bleeding. A meta-analysis. J Clin Gastroenterol. 1991;13(Suppl 2):S44–55.PubMedGoogle Scholar
  73. 73.
    Zinner MJ, Rypins EB, Martin LR, Jonasson O, Hoover EL, Swab EA, Fakouhi TD. Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients. Ann Surg. 1989;210(5):590–5.PubMedCrossRefGoogle Scholar
  74. 74.
    Goldberg AB, Wing DA. Induction of labor: the misoprostol controversy. J Midwifery Womens Health. 2003;48(4):244–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Maury E, Tankovic J, Ebel A, Offenstadt G. An observational study of upper gastrointestinal bleeding in intensive care units: is Helicobacter pylori the culprit? Crit Care Med. 2005;33(7):1513–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009;38(2):245–65.PubMedCrossRefGoogle Scholar
  77. 77.
    Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian critical care trials group. N Engl J Med. 1998;338(12):791–7.PubMedCrossRefGoogle Scholar
  78. 78.
    Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO, Bagin RG, Rock JA, Hepburn B, Laine L. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33(4):760–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Brophy GM, Brackbill ML, Bidwell KL, Brophy DF. Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. Neurocrit Care. 2010;13(2):176–81.PubMedCrossRefGoogle Scholar
  80. 80.
    Daley RJ, Rebuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med. 2004;32(10):2008–13.PubMedCrossRefGoogle Scholar
  81. 81.
    Barletta JF, Erstad BL, Fortune JB. Stress ulcer prophylaxis in trauma patients. Crit Care. 2002;6(6):526–30.PubMedCrossRefGoogle Scholar
  82. 82.
    Pimentel M, Roberts DE, Bernstein CN, Hoppensack M, Duerksen DR. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95(10):2801–6.PubMedCrossRefGoogle Scholar
  83. 83.
    Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004;51(57):757–61.PubMedGoogle Scholar
  84. 84.
    Faisy C, Guerot E, Diehl JL, Iftimovici E, Fagon JY. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med. 2003;29(8):1306–13.PubMedCrossRefGoogle Scholar
  85. 85.
    Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition in patients receiving mechanical ventilation. Multiple sources of tracheal colonization include the stomach. Am J Med. 1980;80(5):827–32.CrossRefGoogle Scholar
  86. 86.
    Garcia Rodriguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007;132(2):498–506.PubMedCrossRefGoogle Scholar
  87. 87.
    Lanas A, Garcia-Rodriguez LA, Arroyo MT, Gomollon F, Feu F, Gonzalez-Perez A, Zapata E, Bastida G, Rodrigo L, Santolaria S, Guell M, de Argila CM, Quintero E, Borda F, Pique JM. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731–8.PubMedCrossRefGoogle Scholar
  88. 88.
    Fisher L, Fisher A, Pavli P, Davis M. Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and prevention. Aliment Pharmacol Ther. 2007;25(3):297–308.PubMedCrossRefGoogle Scholar
  89. 89.
    ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP commission on therapeutics and approved by the ASHP board of directors on November 14, 1998. Am J Health Syst Pharm, 1999;56(4):p. 347–79.Google Scholar
  90. 90.
    Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Clemens M. Schirmer
    • 1
    • 3
  • Joshua Kornbluth
    • 2
  • Carl B. Heilman
    • 1
  • Anish Bhardwaj
    • 1
    • 2
  1. 1.Department of Neurological SurgeryTufts University School of MedicineBostonUSA
  2. 2.Department of NeurologyTufts University School of MedicineBostonUSA
  3. 3.Baystate NeurosurgerySpringfieldUSA

Personalised recommendations